| Bid Price | High Price | ||
|---|---|---|---|
| Ask Price | Low Price | ||
| Open Price | Spread | ||
| Prev Close | Volume |
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Jul 13, 2018 | 2.49 | 2.67 | 2.33 | 2.38 | 856,398 |
| Jul 12, 2018 | 2.70 | 2.70 | 2.33 | 2.38 | 1,185,421 |
| Jul 11, 2018 | 2.51 | 2.70 | 2.33 | 2.50 | 3,067,100 |
| Jul 10, 2018 | 2.60 | 2.68 | 2.43 | 2.63 | 4,714,700 |
| Jul 9, 2018 | 2.67 | 2.74 | 2.30 | 2.63 | 5,539,364 |
| Name | ValiRx | Epic | VAL |
|---|---|---|---|
| ISIN | GB00BWWYSP41 | Currency | GBX |
| Type | Equity | Trading Segment | ASX1 |
| Record Status | Active | Trading Status | Closed |
| Industry | Health Care | Sector | Pharmaceuticals & Biotechnology |
| EMS | 30,000 | Prev Close | 2.38 |
| Shares in Issue (m) | 454.96 | Market Cap (£m) | 10.83 |
| PE Ratio | -1.25 | Div per Share (p) | 0.00 |
| Div Yield | 0.00 | Div Cover | 0.00 |
| EPS | -1.90 | EPS Growth (%) | 77.75 |
| PEG | -0.02 | DPS Growth (%) | n/a |
| ROCE | -112.34 | Net Gearing | 21.94 |
| Quick Ratio | 1.13 | Current Ratio | 1.13 |
| Date | Broker | Recomm. | Price | Old Target | New Target | Notes |
|---|---|---|---|---|---|---|
| 12 Jan | Beaufort Securities | Speculative Buy | 2.38 | - | - | Reiterates |
| 19 Dec | Beaufort Securities | Speculative Buy | 2.38 | - | - | Reiterates |
| 16 Nov | Beaufort Securities | Speculative Buy | 2.38 | 6.50 | 6.50 | Reiterates |
| 13 Oct | Beaufort Securities | Speculative Buy | 2.38 | 6.50 | 6.50 | Reiterates |
| 29 Sep | Beaufort Securities | Speculative Buy | 2.38 | 6.50 | 6.50 | Reiterates |
| Date | Director | Type | Volume / Price | Trade Value |
|---|---|---|---|---|
| 15 Mar 2017 | Satu Vainikka | Buy | 400,000 @ 2.50p | £10,000.00 |
| 15 Mar 2017 | George Morris | Buy | 400,000 @ 2.50p | £10,000.00 |
| 15 Mar 2017 | Gerald Desler | Buy | 400,000 @ 2.50p | £10,000.00 |
| 02 Mar 2017 | Satu Vainikka | Placing | 400,000 @ 2.50p | £10,000.00 |
| 02 Mar 2017 | George Morris | Placing | 400,000 @ 2.50p | £10,000.00 |
